Current:Home > NewsMerck sues U.S. government over plan to negotiate Medicare drug prices, claiming "extortion"-LoTradeCoin
Merck sues U.S. government over plan to negotiate Medicare drug prices, claiming "extortion"
View Date:2024-12-23 16:56:03
Drugmaker Merck is suing the U.S. government over its plan to allow Medicare to negotiate prices for a handful of drugs, calling it "extortion."
The plan, part of the 2022 Inflation Reduction Act, is expected to save taxpayers billions of dollars on common drugs the government pays for. The law directs the Center for Medicare and Medicaid Services to select 10 drugs with no generic or biosimilar equivalents to be subject to government price negotiation. (The list will eventually expand to 20 drugs.)
In its lawsuit, filed on Tuesday in federal court in the District of Columbia, Merck called the program "a sham" that "involves neither genuine 'negotiations' nor real 'agreements.'" Instead, the pharmaceutical firm said the U.S. Department of Health and Human Services selects drugs to be included and then dictates a discount, threatening drugmakers with "a ruinous daily excise tax" if they refuse the conditions.
Merck added that it expects its diabetes treatment, Januvia, to be subject to negotiation in the first round, with diabetes drug Janumet and the cancer drug Keytruda affected in later years.
The Rahway, New Jersey-based drugmaker is seeking to end the program. "It is tantamount to extortion," it said in the complaint.
Health and Human Services Secretary Xavier Becerra, who is named as a defendant in the suit, said in a statement that the agency plans to "vigorously defend" the drug price negotiation plan.
"The law is on our side," he said.
The lawsuit also names HHS and Chiquita Brooks-LaSure, administrator of the Centers for Medicare and Medicaid Services, as defendants.
Merck said the program violates elements of the Constitution, including the Fifth Amendment's requirement that the government pays "'just compensation' if it takes 'property' for public use," according to the complaint.
The drugmaker noted that Congress could have simply allowed HHS to state a maximum price it would pay for a drug, but that would have enabled drugmakers to walk away from talks, leaving millions of Medicare beneficiaries without essential medications, the complaint said.
Instead, Merck said the government uses the threat of severe penalties to requisition drugs and refuses to pay fair value, forcing drugmakers "to smile, play along, and pretend it is all part of a 'fair' and voluntary exchange." This violates the First Amendment, the suit claims, calling the process "political Kabuki theater."
Patient advocate slams Merck
David Mitchell, founder of the advocacy group "Patients For Affordable Drugs Now," slammed Merck's suit as an attempt to "unilaterally set prices that are untethered to quality at the expense of patients."
"The reality is, drug corporations that are subject to Medicare's new authority – and who already negotiate with every other high income country in the world – will engage in a negotiation process after setting their own launch prices and enjoying nine years or more of monopoly profits," Mitchell said in a statement.
He added, "Medicare negotiation is a desperately needed, long-awaited rebalancing of our drug price system that will help millions of patients obtain the medications they need at prices they can afford while ensuring continued innovation."
Medicare is the federally funded coverage program mainly for people who are age 65 and older. Currently, drug companies tell Medicare how much a prescription costs, leaving the federal government and Medicare beneficiaries to pay up.
The Inflation Reduction Act's drug negotiation provisions mark the first time that the federal government will bargain directly with drug companies over the price they charge for some of Medicare's costliest drugs. Government negotiation with drugmakers and price caps on drugs are common in other developed nations.
Republican lawmakers have also criticized President Joe Biden's administration over the drug pricing plan, saying it could deter drugmakers from developing new treatments.
The federal government is expected to soon release rules for negotiating drug prices. In September, it is scheduled to publish a list of 10 drugs that it will start price negotiations on next year. Negotiated prices won't take hold until 2026.
With reporting by the Associated Press.
- In:
- Medicare
- merck
veryGood! (3321)
Related
- The charming Russian scene-stealers of 'Anora' are also real-life best friends
- Trump sons downplay involvement with documents at center of New York fraud trial
- Iranian club Sepahan penalized over canceled ACL match after Saudi team’s walkout
- US applications for jobless benefits inch higher but remain at historically healthy levels
- The 10 Best Cashmere Sweaters and Tops That Feel Luxuriously Soft and Are *Most Importantly* Affordable
- Judge says Alabama lawmaker violated his bond conditions and will remain jailed through the weekend
- Nevada Sen. Jacky Rosen says antisemitic threats hit her when she saw them not as a senator, but as a mother
- Rights groups report widespread war crimes across Africa’s Sahel region with communities under siege
- Jason Statham Shares Rare Family Photos of Rosie Huntington-Whiteley and Their Kids on Vacation
- Mississippi voter registration numbers remain steady heading into Tuesday’s general election
Ranking
- Where is 'College GameDay' for Week 12? Location, what to know for ESPN show
- Six Flags, Cedar Fair merge to form $8 billion company in major amusement park deal
- Suzanne Somers, late 'Three's Company' star, died after breast cancer spread to brain
- Putin signs bill revoking Russia’s ratification of a global nuclear test ban treaty
- A growing and aging population is forcing Texas counties to seek state EMS funding
- Poll shows most US adults think AI will add to election misinformation in 2024
- Director of new Godzilla film pursuing ‘Japanese spirituality’ of 1954 original
- AP Week in Pictures: Global | Oct. 27 - Nov. 2, 2023
Recommendation
-
Knicks Player Ogugua Anunoby Nearly Crashes Into Anne Hathaway and Her Son During NBA Game
-
China and Southeast Asia nations vow to conclude a nonaggression pact faster as sea crises escalate
-
Judge says Alabama lawmaker violated his bond conditions and will remain jailed through the weekend
-
Sam Bankman-Fried is found guilty of all charges and could face decades in prison
-
Kennesaw State football coach Brian Bohannon steps down after 10 seasons amid first year in FBS
-
How the Texas Rangers pulled off a franchise-altering turnaround for first World Series win
-
Jimmy Buffett swings from fun to reflective on last album, 'Equal Strain on All Parts'
-
Hold the olive oil! Prices of some basic European foodstuffs keep skyrocketing